Peer-reviewed and commissioned papers

(* Indicates key publications)
  1. Nargund V, Naik KG: Parotid Tumours: Clinico-pathological study. Antiseptic 1981; 32: 93-7
  2. Schraibman I G, Micheal Z, Nargund VH, Potdar N: Colonoscopic surveillance after diagnosis of carcinoma of colon and rectum. Annales de Chirurgie 1989; 43(7): 568-9
  3. *Nargund VH, Lomas K, Sapherson DA, Flannigan GM, Hamilton Stewart PA:
    Radiographer- performed abdominal and pelvic ultrasound: Its value in urology out-
    patient clinic. British Journal of Urology 1994; 73: 366-70
  4. Nargund VH, Barker IK, Coombs L, Flannigan GM, Hamilton Stewart PA, Crawford SM:
    Growth characteristics of early passage cell lines compared with established TCC
    bladder cell lines. Urological Research 1994; 22: 75-7
  5. Nargund VH, Hamilton Stewart PA: Point of technique: Endoscopic Localisation of
    the lesion prior to partial cystectomy. British Journal of Urology 1994; 73(4): 455-6
  6. Nargund VH, Hockley I, Flannigan GM: Point of technique: Extracorporeal shock wave
    lithotripsy for lower ureteric stones through perineal region. British Journal of Urology
    1995; 75; 410
  7. Nargund VH, Cumming JA, Jerwood D, Sapherson DA, Stewart PAH, Flannigan GM. Ultrasound in urological emergency: results of self audit and implications for training. International Urology and Nephrology 1996; 28; 267-71
  8. *Sugino T, Gorham H, Yoshida K, Boledeoku J, Goodison S, Nargund V, Cranston D,
    Tarin D. Progressive loss of Cd-44 gene expression in invasive bladder cancer. American
    Journal of Pathology 1996; 149: 873-882
  9. Nargund VH and Cranston D W. Urological complications in renal transplantation
    (Review). Transplant Reviews 1996; 10: 24-33
  10. *Yoshida K, Sugino T, Tahara H, Nargund VH, Woodman A, Fellows GJ and Tarin D. Telomerase activity in bladder carcinoma and its implications for non-invasive diagnosis by its detection in exfoliated cancer cells in urine. Cancer 1997; 79: 362-9
  11. *Nargund V H, Lowe J, Flanagan G and Hamilton Stewart P. Role of P-Glycoprotein in
    chemo-resistant superficial bladder tumours. European Urology 1997; 31: 160-2
  12. *Robertson AJ, Nargund V, Gray DWR, Morris PJ. Low dose aspirin as prophylaxis
    against renal vein thrombosis in renal-transplant patients. Nephrology, Dialysis and
    Transplantation 2000; 15: 1865-8
  13. Fenely M, Jan H, Granowska SJ, Mather S, Ellison D, Kirby RS, Oliver RTD, Badenoch
    DF, Chinegwundoh FC, Nargund VH, Paris AMI, Britton KE. Imaging with prostate
    specific membrane antigen (PSMA) in prostate cancer. Prostatic carcinoma & Prostatic
    diseases 2000; 3: 47-52(Review)
  14. Nargund VH, Noble JG, Cranston D and Fellows GJ. Haematuria: A long-term
    problem after prostatectomy. Urologia Internationalis 2001; 66: 1-5
  15. *Ojha K, Nargund V H, Nargund G. Emergency sperm extraction for transient erectile
    dysfunction prior to assisted conception. Journal of Assisted Reproduction and Genetics
    2001; 18: 36-7
  16. * Otite U, Webb J A W, Oliver R T D, Badenoch DF and Nargund VH. Testicular
    microlithiasis: Is it a benign condition with a malignant potential? European Journal of
    Urology 2001; 40: 538-42
  17. * Goonewardene TI, Bozcuk H, Oliver RT, Barua J, Nargund V and Philip T. Phase 1/2
    Study of Synchronous Methotrexate, Cisplatin, Vincristine (MOPq10) Chemotherapy and
    radiation for patients with locally advanced bladder cancer. Urologia Internationalis
    2001; 67: 293-7
  18. *Sohaib A, Theo J, Nargund VH, Hendry WF, Lumley J, Reznek R. Role of MRI in the
    evaluation of vena caval involvement of renal cell carcinoma. Journal of Urology
  19. Nargund VH. Management of testicular pain. The Practitioner 2002; 246: 792-800
  20. Oliver RTD, Ong J, Berney D, Nargund V, Badenoch D and Samash J. Testis conserving chemotherapy in gern cell cancer: Its potential to increase understanding of the biology and treatment of carcinoma in situ. Acta Pathologica Microbiologica et Immunologica Scandanavia 2003:111: 86-91; discussion 91-2
  21. Nargund V H. Editorial comment: Flutamide in recurrent prostate cancer. British Journal of Urology International 2003; 92: 698
  22. *Oliver R T D, Ong J, Shamash J, Ravi R, Nargund V, Harper P, Ostroveski M J, Sizer B, LeVay J, Robinson A, Neal D E, Williams M. Long-term follow up of Anglian germ cell cancer group surveillance versus patients with stage I non-seminoma treated with adjuvant chemotherapy. Urology 2004; 63: 556-61
  23. *Hitchings AW, Kumar M, Jordan S, Nargund V, Martin J, Berney D M. Prediction of
    progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb. British Journal of
    Cancer 2004; 91: 552-7
  24. *Lucas M, Stephenson T, Nargund VH. Tamsulosin in the management of patients in
    acute urinary retention due to BPH. British Journal of Urology International 2005; 95: 354-
  25. *Nargund VH, Al-Hashimi D, Kumar P, Gordon S, Otite U, Ellison D, Carroll M, Baithun
    S, Britton K. Imaging with radio-labelled monoclonal antibody (MUJ 591) to prostate-
    specific membrane antigen (PSMA) in staging of clinically localised prostatic carcinoma:
    Comparison with clinical, surgical and histological staging. British Journal of Urology
    International 2005; 95: 1232-6
  26. *Bhardwa JM, Powell R, Berney D, Baithun S, Nargund VH, Oliver RTD. Assessing the
    size and stage of testicular germ cell tumours 1984-2003. British Journal of Urology
    International 2005; 96:819-21
  27. Otite U, Baithun S, Chinegwundoh FC, Nargund VH, Iles RK. Detection of serum and
    urinary beta human chorionic gonadotrophin (hCGb) in serum or urine is of no clinical
    significance. Tumor Biology 2006; 27 (4): 181-6
  28. Ghani K, Rockall A, Nargund VH, Chinegwundoh F. Comments: Prostate Biopsy: To
    stop anticoagulation or not? British Journal of Urology International 2006; 97(2): 224-5
  29. Kumar P and Nargund V H. Samuel Pepys: A Patient’s Perspective of Lithotomy in
    17th Century England. Journal of Urology 2006; 175(4): 1221-4 (Review)
  30. Kumar P, Kapoor S, Nargund V. Review: Haematospermia. Annals of Royal College of
    Surgeons of England 2006; 88 (4): 339-42
  31. Chinegwundoh FC, Enver MK, Oliver RTD, Nargund VH and Ben-Shlomo Y. Risk and presenting features of prostate cancer amongst African Caribbeans, South Asians and Europeans in Northeast London. British Journal of Urology International 2006; 98:1216-20
  32. *Kumar P, Nargund VH. Management of post-radical prostatectomy anastomotic stricture by endoscopic transurethral balloon dilatation. Scandinavian Journal of Urology and Nephrology 2007; 41(4): 314-5
  33. Keeler B, Ghani KR, Nargund VH. Review- Haematuria 1: risk factors, clinical evaluation and laboratory investigations. British Journal of Hospital Medicine 2007; 68(8): 418-22
  34. Ghani KR, Keeler B, Nargund VH. Review-Haematuria 2: imaging investigations, management and follow up. British Journal of Hospital Medicine2007; 68: 489 – 493
  35. *Ben-Shlomo Y, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Metcalfe C, Persad R on behalf of the PROCESS study group. The risk of prostate cancer amongst Black men in the United Kingdom: The PROCESS retrospective cohort study. European Urology 2008; 53(1):99-105. Epub 2007 Mar 1
  36. *.Haba Y, Williams MV, Neal DE, Ong JY, Ostrowski MJ, Ell PJ, Nargund V, Shamash J, Oliver RT. Stage migration and pilot studies of reduced chemotherapy supported by positron-emission tomography findings suggest new combined strategies for stage 2 nonseminoma germ cell tumour. British Journal of Urology International 2008; 101(5): 570-4
  37. Nargund VH and Grey A. Tamsulosin MR and OCAS (modified release and oral controlled absorption system): current therapeutic uses. Expert Opinion on Pharmacotherapy 2008; 9: 813-824
  38. Nargund VH. Editoreal Comment on ‘A Five-year follow up study of asymptomatic men with testicular microlithiasis’. Journal of Urology 2008; 179: 1423
  39. *Nargund VH. Short Review: Health Issues of Cycling in Men. British Journal of Urology International 2008; 102(7):771-2 Epub 2008 Jun 28. Press Release on 07.07.2008
  40. *Metcalfe C, Patel B, Evans S, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Dorling D, Thomas B, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Persad R, Ben-Shlomo Y. The risk of prostate cancer amongst South Asian men in southern England: The PROCESS cohort study. British Journal of Urology International 2008; 102(10):1407-12. Epub ahead of print 6 June
  41. *Metcalfe C, Evans S, Ibrahim F, Patel B, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Persad R, Ben-Shlomo Y. Pathways to diagnosis for Black men and White men found to have prostate cancer: the PROCESS cohort study. British Journal of Cancer. 2008; 99(7):1040-5 [Epub ahead of print] Press Release 29.09.2008
  42. Evans S, Metcalfe C, Patel B, Ibrahim F, Anson K, Chinegwundoh F, Corbishley C, Gillatt D, Kirby R, Muir G, Nargund V, Popert R, Wilson P, Persad R, Ben-Shlomo Y. Clinical presentation and initial management of Black men and White men with prostate cancer in the United Kingdom: the PROCESS cohort study. British Journal of Cancer 2010;102(2): 249-54. Epub 2009 Nov 24.
  43. Kumar P, Mehta V, Nargund V*. Management of Chronic testicular pain. Urologia Internationalis 2010; 84(2); 125-31
  44. Nargund V* and Zaman F. Radical prostatectomy—too soon to abandon the perineal approach? (Perineal radical prostatectomy versus endoscopic retropubic prostatectomy). Nature Urology Reviews 2011; 8: 179-180
  45. Nargund VH*. Tanabalan C, Kabir M. Management of Non-muscle Invasive Bladder Cancer (NMIBC). Seminars in Oncology (in print) 2012